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Abstract Zymolyase (lyticase) is used for cell wall digestion in yeast experiments and
is needed for incubation processes under moderate experimental conditions. This has
been thought to cause unfavorable effects, and many researchers are aware that the
enzyme method is unsuitable for RNA preparation following several reports of stress
responses to the enzyme process. However, RNA preparation with enzyme digestion
continues to be used. This may be because there have been insufficient data directly
comparing RNA preparation conditions with previous studies. We investigated the
influence of enzyme processes in RNA preparation using a DNA microarray, and
compared superoxide dismutase (SOD) activities with a non-treated control and the
results of previous research. Gene expressions were commonly changed by enzyme
processes, and SOD activities increased only during short-term incubation. Meanwhile,
both SOD gene expressions and SOD activity during RNA preparation indicated
different results than gained under conditions of long-term incubation. These results
suggest that zymolyase treatment surely influences gene expressions and enzyme activ-
ity, although the effect assumed by previous studies is not necessarily in agreement with
that of RNA preparation.
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Zymolyase (lyticase) is a very important enzyme in microbiology, isolated from Arthro-
bacter luteus. Zymolyase actively degrades yeast cell walls [1]. The principal ingredient in
zymolyase is β-1,3-glucan laminaripentaohydrolase, which hydrolyzes glucose polymers
linked by β-1,3-bonds, producing laminaripentaose [1–3]. Zymolyase also includes protease
and mannase. These enzymes strongly degrade yeast cell walls. By changing pH or
temperature, cell wall lysis and dehydration of glucan are easily achievable. For this reason,
zymolyase is frequently used for the preparation of nucleic acids or soluble proteins from
yeast cells, and many commercial kits involving such enzyme treatment have been released.
However, digestion must be performed by incubating at moderate temperature for a given
length of time, thereby having potential to change the yeast reaction. Forsburg [4] introduced
the RNA preparation method, involving 6 U/ml of enzyme at 37 °C for 30 min, and Klassen
[5] introduced 8 U/ml of enzyme over 1 h. These conditions may be considered moderate,
and many commercial kits use higher concentrations (10–500 U/ml) and short-term incu-
bation (15–30 min) at 37 °C. This is a strategy to avoid cell response resulting from
enzymatic treatment.
Recently, there have been a number of studies on the influence of zymolyase. De
Groot [6], for example, measured cell density under 0.1 U/ml concentration at 37 °C for
1–4 h, and also reported the induction of cell wall genes and mitogen-activated protein
kinase (MAPK)-related genes under 0.26 U/ml of zymolyase at 28 °C for 1–4 h, or
0.8 U/ml at 24 °C for 3 h, or 5 U/ml 24 °C for 2 h [7–9]. Bermejo [10] also investigated
the influence of mutation on the MAPK pathway receptor under 0.8 U/ml at 24 °C for
3 h. Since these studies utilize long-term incubation, from 1 to 4 h, at low concentrations
of digestion enzyme, gene expression data show significant changes. However, the
reaction times of digestion reported by these studies are relatively longer than under
RNA preparation conditions. If gene expression changes also occur during short-term
reaction times such as those used for RNA preparation, then RNA preparation using the
digestion method is confronted with a critical problem. Because the concentrations of
digestive enzyme in RNA preparations are generally higher than in enzymatic studies, it
is thought that stress is generated.
Moreover, Bermejo [11] reported that SLT2, a protein kinase of the cell integrity pathway
on the MAPK cascade, was induced by 0.4 U/ml of zymolyase treatment at 24 °C for
15 min, and induction was maximized for 2 h. Generally, the incubation time for zymolyase
treatment is 15–30 min; therefore, this report suggests that unintended gene expressions will
be caused by zymolyase treatment for RNA preparation. What then is the influence of such
treatment? Many recent protocols do not use enzyme treatment because it is known to cause
complications. However, the concentrations and incubation times used in previous research
do not correspond to each other, and therefore information regarding the influence of the
enzymatic process in RNA preparation is insufficient and complicates our understanding of
this method. To address this problem, we investigated the true influence of the enzyme
method on RNA preparation.
There are several methods of yeast RNA preparation. The hot phenol method, the glass
beads method, and the enzyme digestion method are generally used. Since the treatment time
is the shortest in the glass bead method, the possibility of changing the gene expression is
thought to be very low. Phenol denatures cell proteins and enzymes, so the hot phenol
method is expected to suspend cell activity promptly. We used a commercial kit able to
exploit the advantages of both methods. The influence of enzyme treatment was detected as
gene expression changes using a DNA microarray.
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Materials and Methods
Yeast Strain and RNA Preparation
Cells were prepared from yeast (Saccharomyces cerevisiae) strain BY4743 (MATa/α his3Δ1/
his3Δ1 leu2Δ0/leu2Δ0 LYS2/lys2Δ0 met15Δ0/MET15 ura3Δ0/ura3Δ0; Open Biosystems,
Huntsville, AL, USA). The frozen (−80 °C) glycerol stocks of yeast cells were transferred with
an inoculating needle into 10 ml of YPD medium (1 % yeast extract, 2 % peptone, and 2 %
glucose) in glass tubes, and incubated on a rotary shaker at 150 rpm and 25 °C for 2 days until the
stationary phase. The cells were transferred to new flasks, and cell density was adjusted to 0.2–
0.3 at an absorbance of 650 nm (A650). Yeast cells in the flasks were incubated with 150-rpm
rotation at 25 °C for a few hours, until the A650 became about 1.0, and then a cell pellet was
obtained by centrifuging at 3,000 rpm for 5min. Total RNAwas prepared using a commercial kit
(FastRNA Pro Red kit; MP Biomedicals, Irvine, CA, USA). A non-treated control sample was
prepared through following the manufacturer’s instructions. To prepare a zymolyase-treated
sample, zymolyase 20T (Seikagaku, Tokyo, Japan) was dissolved in buffer solution [0.9 M
sorbitol, 0.1 M EDTA, 50 mM DTT (pH 7.5); stock solution concentration 600 U/ml], and this
was added to the cell pellet (final concentration 300 U/ml). This was incubated at 37 °C for
10 min before following the manufacturer's instructions. For a low concentration zymolyase
sample, zymolyase solution was added to the diluted cells (A650=0.2–0.3, final concentration
4 U/ml), and this was incubated with 150 rpm rotation at 25 °C for 2 h. RNA preparation was
performed in the same way as for the non-treated control.
DNA Microarray Analysis
Total RNA samples of the non-treated control and the zymolyase (300 U/ml) treatment were
prepared. To avoid contamination by genomic DNA, RNA samples were treated with DNase
(DNase I; Takara, Shiga, Japan) before reverse transcription. The quality of total RNA was
evaluated using a nucleic acid analyzer (Experion; Bio-Rad, Hercules, CA, USA). RNA samples
were used for synthesizing labeled RNA (amplified RNA) using a 3′ IVTExpress kit (Affymetrix,
Santa Clara, CA, USA). DNAmicroarrays (GeneChip Yeast Genome 2.0 array; Affymetrix) were
processed following the manufacturer’s instructions. Array data sets were transferred into Gene-
Spring analysis software (ver. 10; Agilent Technologies, Santa Clara, CA, USA), and cluster
analyses were performed for each treatment. After using the MAS5 algorithm to obtain summa-
rized probe-level expression data, the average expression of three replicates was normalized to the
control. The T test algorism was used for statistical analysis, and differences in gene expression
with a p value <0.05 (p<0.05) and a fold change >2.0 (FC>2.0) were considered significant.
However, all extracted genes (p<0.05) were checked to find the expression trend within each
category. To avoid the detection of false positives, a multiple testing correction (Benjamini–
Hochberg FDR)was used to obtain corrected p values. Selected genes were categorized following
the annotation used by theMunich Information Center for Protein Sequences (MIPS [12]) and the
Saccharomyces Genome Database (SGD [13]). Several clusters were visualized using spread-
sheet software (Excel 2007; Microsoft, Redmond, WA, USA). The microarray dataset has been
assigned accession number GSE36955 in the Gene Expression Omnibus Database (GEO [14]).
Intracellular SOD Activity
To avoid the inhibition of measurement of SOD activity, zymolyase was dissolved into
another buffer solution (0.9 M sorbitol, 0.1 M EDTA) not containing DTT. The non-treated
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control and the zymolyase treatment cells were collected in microcentrifuge tubes, and
the cell pellets were stored on ice. Samples were washed three times with PBS containing
protease inhibitor (1 pellet/10 ml, Complete mini EDTA-free; Roche, Basel, Switzerland),
and finally, 50 μl of PBS was left in each microtube. A small volume of 0.5 mm
sterilized glass beads was added to the microtube, and cell samples were ground by
pestle for 3 min on ice. Then 450 μl of PBS was added to each microtube, and these
were centrifuged at 10,000×g and 4 °C for 15 min. The supernatant was used as each
sample. Samples were used in the SOD Assay Kit (Dojindo, Kumamoto, Japan), and
measurements followed the manufacturer’s instructions. Because SOD inhibits the trans-
formation from WST-1 (2-(4-lodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tet-
razolium) to WST-1 formazan, we observed the inhibition rate (%) and conversion into
SOD activity (U/mg).
Semi-quantitative PCR
cDNA templates were synthesized from total RNA samples using a commercial reverse
transcription kit (Transcriptor First Strand cDNA Synthesis Kit; Roche). Sequence informa-
tion was obtained from SGD for the target genes (SLT2, SOD1, and SOD2), and primer sets
that corresponded to the position around the 3′-end sequences were designed using the
Primer 3 web site [15]. The following primer sets, SLT2 (forward, 5′-CTCAAGAGAGTAT
GATGGAGATGAGA-3′; reverse, 5′-GTGATTCTATACTTCCCCGGTTACT-3′), SOD1
(forward, 5′-ATCAAGCTTATCGGTCCTACCTC-3′; reverse, 5′-GAATGAATTG
ATGCGCTTACTACTT-3′), and SOD2 (forward, 5′-TTGTTCAAACCTACAACCAGGAT
AC-3′; reverse, 5′-TTCTTTCTTTCTTCAGATCTTGC-3′) corresponded to each target se-
quence. ACT1 was used as an internal control. The ACT1 primer set (forward, 5′-ATTGCC
GAAAGAATGCAAAAGG-3′; reverse, 5′-CGCACAAAAGCAGAG ATTAGAAACA-3′),
which has the same sequence as in a previous report [16], was prepared. For quantification,
positive control templates for constructing standard curves were prepared using standard
PCR. We prepared 20 μl of reaction solutions [1 μl of each 10 μM primer, 4 μl 5× buffer,
1.4 μl 25 mM MgCl2, 0.6 μl 10 mM dNTPs, 1 μl DNA template, 11 μl distilled water, and
0.1 μl taq polymerase (KAPA taq Extra; Kapa Biosystems, Woburn, MA, USA)] and
subjected this to 95 °C for 2 min, followed by 30 cycles of 95 °C for 25 s, 55 °C for 15 s,
and 72 °C for 45 s, in a thermal cycler (C1000; Bio-Rad). For each probe set, a template
dilution series was prepared from these PCR products, and 1 μl of the samples was
dispensed into a 96-well PCR plate. The same volume of control or zymolyase-treated
templates was also dispensed into the plate. A total of 19 μl of reaction mix [0.4 μl of each
10 μM primer, 8.2 μl distilled water, and 10 μl 2× Master mix (KAPA SYBR FAST qPCR
kit; Kapa Biosystems)] was added to the PCR plate. The sample plate was subjected to 95 °C
for 20 s, followed by 40 cycles of 95 °C for 3 s and 62 °C for 20 s, in a thermal cycler
(MX3000P; Agilent Technologies). The amplified ACT1 product was used as an internal
control, and triplicates were averaged.
Results and Discussion
Gene Expression Changes from Zymolyase Treatment
Zymolyase reaction conditions are variously optimized by commercial kits. Moreover,
various concentrations of zymolyase (approximately 10 to 1,000 U/ml) are used. Conditions
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that involve low concentrations (approximately 0.1 to 5 U/ml) have been thought not able to be
evaluated using the results of former studies. Hence, we prepared a 300 U/ml concentration of
zymolyase solution, and 100 μl of the solution was added to a yeast cell pellet. The sample was
incubated for 10 min and then compared with a non-treated control sample using gene
expression analysis. The microarray result extracted 3,218 gene expression changes from a
total of 5,714 probes mounted on the DNA microarray (p<0.05). Moreover, 1,529 induction
genes and 1,689 repression genes were also counted from the total extracted genes, and a
significant deviation to one side was not observed (Fig. 1). Meanwhile, a total of 537 genes
indicated a more than 2-fold gene expression change; 435 of these genes indicated
induction, and 112 indicated repression. Since much research has focused on gene
induction, incorrect signals may be obtained by this expression analysis.
Functional classification was performed on extracted genes, indicating a more than 2-fold
expression change (Table 1). The ratio of detection in the secondary metabolism category
was the highest. However, whole categories indicated a certain level of detection ratio, and
therefore a significant change was not observed in almost all functional categories except for
protein synthesis. A total of 469 protein synthesis genes were contained in the yeast genome
DNA microarray, and considering this, the detection number within this category seemed
comparatively low. This implies that protein synthesis processes were not strongly induced
because of short-term digestion. Meanwhile, localization classification indicated significant
changes in cell wall synthesis-related categories (Table 2). However, a large number of
detection genes were observed in the cytoplasm, nucleus, and mitochondria rather than in the
cell wall-related genes. Taken together, the results of both functional and localization
classifications suggested that the expression of many functional genes was changed by
zymolyase treatment.
Activation of RNA Polymerase
Because the transcription process is essential for gene expression, we observed signif-
icantly changed (FC>2.0) RNA polymerase-related genes. In Table 1, the detection ratio
Fig. 1 Gene expression profiles
following zymolyase treatment.
FC fold change, con non-treated
control, zym 300 U/ml for 10 min
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of transcription-related genes (9.3 %) corresponds to the average (around 10 %) in all
functional categories; this category did not therefore show significant characteristics.
However, the class of RNA polymerase was biased; a number of RNA polymerase II-
related genes that work on transcription of mRNA indicated more than 2-fold changes,
while only a small number of genes in classes I and III showed the same changes
(Fig. 2). This finding suggests that short-term zymolyase reaction causes the induction
of mRNA transcription.
Regulation of Cell Wall Genes
Changes in cell wall synthesis-related genes following zymolyase treatment have been well
reported [6–9, 17]. Moreover, detection ratios in cell wall synthesis categories at localization
classification were significantly large, so we investigated the genes in this category. For
instance, both FIT1 and FIT3, required for smooth metabolism with iron conservation in
periplasmic space [18], were induced by the enzyme treatment. This might have been used
against cell lysis by cell wall repair and the activation of cellular metabolism. However, not
many genes indicated greater than 2-fold change (Fig. 3a), and expression of SLT2, which
Table 1 Functional classifica-
tions of detected genes
aFunctional categories referred
to MIPS [12]bProbe set number






Amino acid metabolism (171)b 25 10.2
Nitrogen and sulfur metabolism (93) 8 8.2
Nucleotide metabolism (221) 17 7.5




Lipid, fatty acid, and isoprenoid
metabolism (287)
35 12.5
Metabolism of vitamins, cofactors (158) 17 10.4
Secondary metabolism (76) 17 21.8
Energy (339) 38 10.6
Cell cycle and DNA processing (969) 85 8.5
Transcription (1,012) 95 9.3
Protein synthesis (469) 22 4.6
Protein fate (1,133) 98 8.5
Protein with binding function (1,026) 110 10.6
Protein activity regulation (245) 18 7.4
Cellular transport (1,010) 111 10.7
Cellular communication (231) 20 8.5
Cell rescue (521) 63 11.4
Cellular interaction (445) 47 10.3
Development (67) 7 10.0
Biogenesis of cellular components (844) 83 9.7
Cell type differentiation (449) 47 10.5
Unclassified proteins (879) 85 4.3
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codes mitogen-activated protein kinase (MAPK) in the cell integration pathway and is
related to cell wall remodeling [19], was a little less than 2-fold (data not shown). A former
study reported that 15 min of zymolyase treatment did not cause significant change to SLT2
compared with 2 h of treatment [11]. Meanwhile, RNA preparation uses high concentrations
(300 U/ml) of zymolyase, and this does not correspond with former studies. We therefore
prepared a sample with low zymolyase concentration (4 U/ml) and long-term incubation
(2 h) to enable comparison with former studies (Table 3). Our semi-quantitative PCR
indicated that zymolyase treatment for RNA preparation resulted in a small induction shown
in the DNA microarray results (Fig. 3b). Likewise, the sample that was under long-term
incubation indicated relatively high induction though it was less than 2-fold. The induction
level of SLT2 was proportional to incubation time, but not to enzyme concentration. Taken
together, we thought that RNA preparation with short-term incubation (10–15 min) only
caused slight changes to cell wall genes.
However, DAN genes indicated large expression changes, and also TIR1, 3, and 4 were
induced more than 3-fold. DAN1 and TIR1–4 each code homologous mannoproteins [20].
The expression of cell wall genes and, in particular, the expression of many mannoprotein
genes was induced. These changes suggest that yeast cells respond to enzyme treatment.
Induction of MAPK Pathway Genes
Slt2 is a component of the MAPK pathway, and therefore we believe that up-stream and
down-stream genes were also influenced by zymolyase treatment. We extracted MAPK-
related genes, and these were categorized based on the Kyoto Encyclopedia of Genes and
Genomes (KEGG [21]). According to our previous studies, MAPK genes did not show
significant expression changes (p<0.05; fold change, FC>2.0) even under highly toxic
Table 2 Localization of detected
genes
aCellular localization referred to
MIPS [12]bProbe set number
mounted on array chip
Localizationa Detection number Detection ratio (%)
Cell wall (40)b 12 30.0
Extracellular (49) 12 24.5
Cytoskeleton (202) 34 16.8
Integral membrane (158) 21 13.3
Cell periphery (211) 26 12.3
Punctate composite (131) 16 12.2
Bud (145) 17 11.7
ER (521) 56 10.7
Plasma membrane (181) 19 10.5
Cytoplasm (2,645) 275 10.4
Nucleus (2,036) 191 9.4
Vacuole (269) 25 9.3
Endosome (54) 5 9.3
Transport vesicle (137) 12 8.8
Mitochondria (993) 84 8.5
Ambiguous (225) 19 8.4
Golgi (154) 12 7.8
Golgi membrane (94) 4 4.3
Peroxisome (52) 1 1.9
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conditions [22, 23]. Hence, we extracted all MAPK genes that indicated changes (p<0.05,
FC>1.0) (Fig. 4). The extracted genes belonged to various MAPK pathways, and they
included GTPase-coding genes such as CDC42 and RHO1 [24, 25], and the cellular
membrane receptor genes, SHO1, WSC2, and STE3 [26–29]. Those receptor and GTPase
genes indicated repression trends. Conversely, the down-stream genes of MAPKKK in each
MAPK pathway pointed to a trend in gene induction. While the reason for repression of up-
stream genes was uncertain, this result suggested that these MAPK pathways were induced
by zymolyase treatment, regardless of functional category. Moreover, DIG1 and 2 coding
proteins, Dig1 and 2, bind Ste12, and function as inhibition regulators down-stream of the
MAPKFilamentation orMating pathway [30]; these indicated a different manner of expression.
Because it has been reported that Dig1 and 2 regulate Ste12 differently from each other [31], it
was thought that the differences in gene expression reflected the regulatory manner of Ste12.
STE12 expression was not observed, whereas the genes of both TEC1 andMCM1, which bind
Ste12 to form a complex [32, 33], were also induced. Expression of TEC1 andMCM1, and also
ofMSN2 andRLM1, was induced, and these changes corresponded to the expression patterns of
up-stream genes such as FUS3, SLT2, andHOG1. MAPK pathways were thought to be induced
by zymolyase treatment regardless of differences in functional cascade.
Oxidative Stress Responses and Intracellular SOD Activity
Since enzymatic digestion is thought to cause oxidative stress conditions in cells, we also
extracted the oxidative stress response genes. Only a small number of genes were observed
to indicate significant change (FC>2.0), although we extracted all oxidative response genes
(p<0.05, FC>1.0) (Fig. 5a). The result of extraction number did not indicate bias between
induction and repression. One third of the oxidative stress response genes coded for
mitochondria-located proteins, and the others coded for cytoplasm- or nucleus-located
proteins. Previous studies have not to this extent reported oxidative stress response genes
during cell digestion [8, 9]. Our study indicated small expression changes. However,
oxidative stress is the most likely stressor causing damage to cells, and it is possible that
Fig. 2 Gene expression changes
induced by RNA polymerase.
RNA polymerase-coding genes,
which indicated significant
changes (FC>2.0), were extracted.
The gene expressions of non-
treated control samples were
adjusted 1-fold. FC fold change
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zymolyase treatment causes oxidative, stress-derived damage [34]. Hence, we tried to
observe intracellular oxidative stress responses through the comparison of SOD activity.
SOD1 and 2, encoding superoxide dismutase [35, 36], were also detected and slightly
induced. SOD is a major anti-stressor of cells, so it was expected that SOD activity would
accurately reflect the intracellular circumstances. The method we used measured SOD
activity but not enzyme volume because it monitored the inhibition reaction of free SOD
(see “Materials and Methods” section). Sod1 is localized in the cytoplasm, nucleus, and
mitochondria, while Sod2 is localized in the mitochondrial membrane surfaces. However,
we did not make allowances for the localization of SOD because the sample preparation for
Table 3 Zymolyase treatment
conditions Con Zym Zym 2 h
Time 0 10 min 2 h
Zymolyase (U/ml) – 300 4
Fig. 3 Gene expression changes
in cell wall genes. Cell wall
protein-coding genes which
indicated significant changes
(FC>2.0) were extracted (a). To
enable comparisons with previous
research, the gene expression of
SLT2 was measured by semi-
quantitative PCR (b). FC fold
change, con non-treated control,
Zym 300 U/ml for 10 min, Zym 2h
4 U/ml for 2 h. Bars = SE. n=3
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this monitoring was not suitable for separating the levels of SOD activity. We also used a
low concentration (4 U/ml) zymolyase-conditioned sample with long-term incubation (2 h),
so that this could be easily compared with previous studies. The non-treated control indicated
175 U/mg (SE=4), 300 U/ml of zymolyase-conditioned sample indicated 220 U/mg (SE=12),
and the low concentration (4 U/ml) zymolyase-conditioned sample indicated 117 U/mg (SE=
18) (Fig. 5b). Compared with the non-treated control, SOD activity in the high concentration
zymolyase sample increased 26 %, while that in the low concentration sample decreased 33 %,
and each zymolyase sample indicated statistical significance (p<0.01). The decrease in SOD
activity in the long-term incubated sample complicated the interpretation of the effect of
zymolyase treatment. We cannot be sure of the cause. However, regardless of time course or
enzyme concentration, SOD activities changed in enzyme-treated samples. Considering the
gene expression changes in SOD genes obtained by semi-quantitative PCR, the change in SOD
activity corresponds to the gene expressions of SOD (Fig. 5b). These findings suggest that
zymolyase treatment in RNA preparation causes changes in gene expression and enzymatic
activity, which, although small, should not be ignored.
Conclusion
RNA preparation from yeast cells is an important and basic technique in molecular biology.
A number of RNA preparation methods have been proposed and adopted. However, this has
included great variation in technique following large differences in equipment between
Fig. 4 Gene expression changes in the MAPK pathway. MAPK pathway genes (FC>1.0, p<0.05) were
extracted and classified to each pathway. The root structure of MAPK was constructed by referring to KEGG
[20]. Lined box, induced gene; dashed line box, repressed gene. MAPKKK MAP kinase kinase kinase,
MAPKK MAP kinase kinase, MAPK MAP kinase
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laboratories. The development of zymolyase treatment has been welcomed to overcome this
problem. Northern hybridization analysis, in particular, needs large quantities of RNA.
Therefore, enzymatic digestion suitable for bulk preparation of RNA was hailed as an
appropriate technique. In recent years, new techniques such as real-time PCR have been
developed, for which large quantities of RNA are not necessary. Recent reports have
recommended avoiding enzymatic digestion [37], and this method has already been ignored
by many other reports describing RNA preparation. It is thus almost time to stop using
Fig. 5 Oxidative stress
responses. Oxidative stress
response genes (FC>1.0, p<0.05)
were extracted and classified to
each localization (a). FC fold
change. SOD expressions and
SOD activity (b). Dashed line
graph, SOD1 expression; line
graph, SOD2 expression; gray
bar graph, SOD activity. con non-
treated control, Zym 300 U/ml for
10 min, Zym 2h 4 U/ml for 2 h.
Bars = SE. n=3
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enzymatic digestion. Our study and other previous studies suggest that yeast cells respond to
stress during the incubation process. Only small changes are indicated; however, mRNA
levels will not reflect the original data that we want to obtain. In particular, the MAPK
pathway genes and the RNA polymerase genes influence many of the other gene categories,
producing moderate changes. It is possible to miss the changes produced by zymolyase
treatment, meaning a great loss in research understanding. To avoid this situation, scientists
should pay attention to careful interpretation of the effects of enzymatic reactions.
Open Access This article is distributed under the terms of the Creative Commons Attribution License which
permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source
are credited.
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